H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses

Vaccine
Kutubuddin MahmoodTed M Ross

Abstract

In this study, recombinant virus-like particles (VLPs) were evaluated as a candidate vaccine against emerging influenza viruses with pandemic potential. The VLPs are composed of the hemagglutinin (HA), neuraminidase (NA), and matrix 1 (M1) proteins of the H5N1 A/Indonesia/05/2005 (clade 2.1; [Indo/05]) virus, which were expressed using baculovirus in Spodoptera frugiperda (Sf9) cells. Ferrets received either 2 injections of the VLP vaccine at escalating doses (based on HA content), recombinant HA, or were mock vaccinated. Vaccinated ferrets were then challenged with either H5N1 Indo/05 or H5N1 A/Viet Nam 1203/2004 (VN/04) wild-type viruses. All ferrets that received the VLP vaccine survived regardless of the VLP dose or challenge strain, whereas seven of eight mock vaccinated ferrets died. The VLP vaccine induced HAI antibodies against the homologous H5N1 clade 2.1 strain, as well as heterologous strains from H5N1 clades 1, 2.2, and 2.3. The magnitude of the HAI titers correlated with VLP dose. Neutralizing antibody responses against the Indo/05 and VN/04 strains showed a similar pattern. Affinity of the anti-HA antibodies raised by the H5N1 Indo/05 VLPs had a higher association rate to the homologous clade 2.1 HA than to the c...Continue Reading

References

Sep 30, 2005·The New England Journal of Medicine·John H BeigelUNKNOWN Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5

❮ Previous
Next ❯

Citations

Dec 16, 2010·Future Microbiology·Melanie CochraneKenneth W Beagley
Apr 30, 2010·Expert Reviews in Molecular Medicine·Neetu SinghSuresh K Mittal
Feb 16, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ming-Wei ChenChi-Huey Wong
Mar 2, 2013·Journal of Virology·Lindomar PenaDaniel R Perez
May 2, 2009·Archives of Pharmacal Research·Kyungdong BaeByungki Hur
Apr 12, 2012·Virologica Sinica·Shu-fen LiFei Deng
Jun 12, 2012·Virologica Sinica·Ma-ping DengFei Deng
May 14, 2010·Animal Health Research Reviews·Wenjun Ma, Jürgen A Richt
Nov 3, 2011·Expert Review of Vaccines·Luigi BuonaguroFranco M Buonaguro
Apr 22, 2011·Expert Review of Vaccines·Ramadevi Raghunandan
Dec 22, 2009·Expert Review of Vaccines·Rogier BodewesAlbert D M E Osterhaus
Jun 4, 2010·Expert Review of Vaccines·Stephen HeartyRichard O'Kennedy
Oct 7, 2010·Expert Review of Vaccines·António RoldãoPaula M Alves
Jul 28, 2013·Expert Review of Vaccines·Christopher H CleggSusan L Baldwin
Apr 8, 2009·Expert Review of Vaccines·De-chu C TangKent R Van Kampen
Apr 8, 2009·Expert Review of Vaccines·Jessica A ChichesterVidadi Yusibov
Apr 8, 2009·Expert Review of Vaccines·Joel R Haynes
Aug 3, 2011·Expert Review of Vaccines·Jimmy A Mena, Amine A Kamen
Jun 4, 2013·Virus Research·Mariana BazKanta Subbarao
May 3, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Seyed Davoud JazayeriAbdul Rahman Omar
Aug 10, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Fu-Shi QuanSang-Moo Kang
Jun 24, 2010·Trends in Molecular Medicine·Florian Krammer, Reingard Grabherr
Mar 23, 2010·Journal of Virological Methods·Florian KrammerReingard Grabherr
Apr 21, 2009·Virus Research·Sang-Moo KangRichard W Compans

❮ Previous
Next ❯